Ir a las Transacciones
Salud

First Coast Mohs has been acquired by AQUA Dermatology

Dermatology and skin cancer specialist First Coast Mohs has partnered with AQUA Dermatology.

First Coast Mohs offers Mohs surgery, surgical and medical dermatology, dermatopathology, cosmetic and laser treatments, electrolysis and other aesthetic services from four state-of-the-art facilities in metro Jacksonville, Florida. The practice features seven clinicians, including two Mohs surgeons, two board certified dermatologists and three Advanced Practice Providers. First Coast Mohs was founded in 2002 by Dr. Scott Warren, who will continue to lead the practice following the transaction.

AQUA Dermatology, backed by Gryphon Investors and GTCR, is the largest dermatology practice in the southeastern United States with over 110 locations and 250 providers. For more than 25 years, the company has treated patients of all ages suffering from skin diseases, acne, sun damage, skin cancer and vein health issues, as well as those seeking cosmetic and plastic surgery. With First Coast Mohs, AQUA Dermatology now has 78 locations in Florida.

Oaklins Heritage in Jacksonville served as the intermediary and exclusive financial advisor to the seller in this transaction.

Partes
“The Oaklins Heritage team helped me far beyond my expectations. Their expertise in all aspects of the process, from start to finish, was very detailed and all-encompassing.”

Dr. Scott Warren

Owner, First Coast Mohs

Contáctese con el equipo de la transacción

Daniel Edelman

Principal
Jacksonville, Estados Unidos
Oaklins Heritage

Dan Curran

Principal
Jacksonville, Estados Unidos
Oaklins Heritage

Alex Kellison

Principal
Jacksonville, Estados Unidos
Oaklins Heritage

Mike Bouton

Asociado
Jacksonville, Estados Unidos
Oaklins Heritage

Transacciones relacionadas

Medicija has acquired Saulės Šeimos Medicinos Centras
Salud

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Aprenda más
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Salud

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Aprenda más
IXICO has completed a fundraising
Salud

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Aprenda más